Global Food Allergy Market Size study, by Food Source (Dairy Products, Poultry Products, Tree Nuts, Peanuts, Shellfish, Wheat, Others), by Diagnosis (Skin-prick Tests, Blood Test, Elimination Diet, Others), by Treatment Type (Epinephrine, Antihistamines,

Global Food Allergy Market Size study, by Food Source (Dairy Products, Poultry Products, Tree Nuts, Peanuts, Shellfish, Wheat, Others), by Diagnosis (Skin-prick Tests, Blood Test, Elimination Diet, Others), by Treatment Type (Epinephrine, Antihistamines, Oral Immunotherapy, Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Regional Forecasts 2022-2032

The Global Food Allergy Market was valued at approximately USD 36.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.9% over the forecast period 2024-2034. Food allergy is an immune system reaction that occurs when the body mistakenly identifies a specific food protein as harmful. This erroneous immune response triggers a range of symptoms, which can vary from mild, such as hives and itching, to severe, such as anaphylaxis, a potentially life-threatening condition characterized by difficulty breathing, a drop in blood pressure, and loss of consciousness. Common allergenic foods include peanuts, tree nuts, milk, eggs, soy, wheat, fish, and shellfish. Food allergies can develop at any age and may persist throughout life or resolve over time. Managing food allergies involves strict avoidance of the offending foods, careful reading of food labels, and carrying emergency medication like epinephrine to treat accidental exposures.

The exponential growth of the Global Food Allergy Market is primarily driven by the rise in the number of patients aged 18 and below coupled with increasing cases of asthma resulting from the intake of allergenic foods. Various government and private entities are providing substantial monetary support to devise medications against food allergies. Food allergy refers to an immune system reaction to certain food substances, which can trigger symptoms such as swollen airways or digestive issues. In severe cases, food allergies can lead to life-threatening reactions like anaphylaxis. The rise in funding for allergy treatments is catalyzing advancements in research and improving access to innovative therapies. For instance, in September 2022, COUR Pharmaceuticals completed a financing round worth USD 30 million to support the expansion of its innovative immune-modifying nanoparticles technology platform.

Companies operating in the food allergy market are focused on developing injectable as well as oral drugs to combat food allergies, especially in cases of accidental exposure to allergenic foods. These companies are also exploring untapped geographies in Asia Pacific, Latin America, and the Middle East & Africa to expand their market presence.

The key regions considered in the study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. The North American region is the leading and fastest-growing region in the global food allergy market. This growth is driven by the high prevalence of food allergies, increased awareness and diagnosis, and a robust healthcare system that supports advanced allergy testing and treatment options. In the United States and Canada, rising rates of food allergies among both children and adults have led to greater demand for innovative therapies, including allergen immunotherapy and advanced diagnostic tools. Additionally, public awareness campaigns and educational programs about food allergies contribute to the growth of the market. Regulatory support for food labeling and safety standards further enhances market expansion, making North America a key player in the food allergy market.

Major market players included in this report are:

Akorn Operating Company LLC

Pfizer Inc.

GSK plc

Novartis AG

Mylan N.V.

Teva Pharmaceutical Industries Ltd.

Sanofi S.A.

Boehringer Ingelheim

AstraZeneca plc

Bayer AG

Merck & Co., Inc.

F. Hoffmann-La Roche Ltd.

EpiPen (owned by Mylan)

Sierra Allergy

Pharmaxis Ltd.

The detailed segments and sub-segment of the market are explained below:

By Food Source:

Dairy Products

Poultry Products

Tree Nuts

Peanuts

Shellfish

Wheat

Others

By Diagnosis:

Skin-prick Tests

Blood Test

Elimination Diet

Others

By Treatment Type:

Epinephrine

Antihistamines

Oral Immunotherapy

Others

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Italy

Spain

Rest of Europe

Asia Pacific

China

India

Japan

Australia

South Korea

Latin America

Brazil

Mexico

Rest of Middle East

Middle East & Africa

Saudi Arabia

South Africa

Rest of Middle East and Africa

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.

Annualized revenues and regional level analysis for each market segment.

Detailed analysis of geographical landscape with Country level analysis of major regions.

Competitive landscape with information on major players in the market.

Analysis of key business strategies and recommendations on future market approach.

Analysis of competitive structure of the market.

Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.